U.S. Medical Equipment Stock News

Parker-Hannifin (NYSE:PH) has announced an 11% increase in its quarterly dividend. This marks the company’s 304th consecutive quarterly dividend payment. The new dividend continues Parker-Hannifin’s long history of returning cash to shareholders. Parker-Hannifin, trading at $872.69, has seen its stock return 43.5% over the past year and 197.0% over the past 5 years. Those numbers, alongside a value score of 1, frame this 11% dividend hike as part of a broader story of shareholder-focused...

Jack Welch Management Institute at Strayer University was ranked #8 among U.S. online MBA programs by CEO Magazine. The program was also ranked #30 among global online MBA programs. This is the 10th consecutive year the institute has been included in the U.S. top 10. For investors watching Strategic Education (NasdaqGS:STRA), this recognition highlights an important asset within the group. JWMI sits inside Strayer University, giving the company a branded MBA offering in a crowded online...

TransDigm Group (TDG) has just posted another set of detailed numbers, with Q1 2026 revenue at US$2.3b and basic EPS of US$6.63, supported by trailing twelve month revenue of US$9.1b and EPS of US$31.08. Over recent quarters the company has seen revenue move from US$2.2b in Q4 2024 to between roughly US$2.0b and US$2.4b through 2025, while quarterly EPS ranged from US$5.79 to US$8.47, setting up a picture of robust scale and consistent profit generation as margins hold close to 20%. See our...

If you are wondering whether CRISPR Therapeutics at around US$52 per share looks like an opportunity or a stock to be cautious on, the key is understanding what that price actually builds in. The stock has delivered a 58.0% return over the last year, even though the year to date return is slightly negative at 2.6%, with shorter term moves of 0.6% over 7 days and 5.8% over 30 days adding extra noise on top. Recent headlines around CRISPR Therapeutics have focused on its gene editing platform...

Valaris (VAL) sets the stage with profit-heavy recent results Valaris (VAL) heads into its Q1 2026 update off a very earnings rich 2025 finish, with Q4 revenue of US$537.4 million and basic EPS of US$10.32, underpinned by trailing twelve month net income of US$982.8 million and EPS of US$13.92. Over the past year the company has seen revenue hold around the US$2.4 billion mark on a trailing basis while quarterly revenue moved from US$620.7 million in Q1 2025 to US$537.4 million in Q4 2025,...

Paymentus Holdings (PAY) has just reported its Q1 2026 results against a backdrop where Q4 2025 revenue was US$330.5 million and basic EPS came in at US$0.16, while trailing twelve month EPS reached US$0.53 on revenue of about US$1.2 billion and earnings growth was cited at 51.5% year over year. Over the past six quarters, the company has seen quarterly revenue move from US$231.6 million in Q3 2024 to US$330.5 million in Q4 2025, with basic EPS ranging from US$0.11 to US$0.16. Trailing...

Huntington Ingalls Industries (HII) has opened Q1 2026 earnings season with a backdrop of solid recent numbers, capped by Q4 2025 revenue of US$3.5 billion, basic EPS of US$4.05, and quarterly net income of US$159 million. These figures together feed into trailing twelve month EPS of US$15.39 on US$12.5 billion of revenue. Over the past few quarters, the company has reported revenue of US$2.7 billion in Q1 2025, US$3.0 billion in Q4 2024, and US$3.5 billion in Q4 2025, while quarterly basic...

If you are wondering whether DXC Technology's current share price lines up with its underlying value, this article will walk through the key signals to help you frame that question clearly. At a last close of US$11.86, the stock shows a mixed recent return profile, with a 2.9% gain over the past week but declines of 6.3% over 30 days, 15.8% year to date and 23.5% over the last year, extending to 47.7% over three years and 65.1% over five years. These price moves sit against a backdrop of...

Energy Transfer (ET) opened the 2026 earnings season with Q1 numbers that sit against a backdrop of steady top line and consistent profitability over the last year, with trailing twelve month revenue at about US$85.5b and basic EPS of US$1.22. The company has seen quarterly revenue range from US$19.2b to US$25.3b across 2025, while basic EPS moved from US$0.37 in Q1 2025 to US$0.25 in Q4 2025, setting the stage for investors to focus on how much of that earnings power can be maintained...

Surgery Partners (SGRY) has just wrapped up Q1 2026, with its latest reported quarter, Q4 2025, showing revenue of US$885 million and a basic EPS loss of US$0.12, alongside net income excluding extra items of a US$15 million loss. Looking back over 2025, the company reported revenue increasing from US$776 million in Q1 to US$885 million in Q4, while quarterly basic EPS losses ranged from US$0.30 in Q1 to US$0.02 in Q2 and US$0.18 in Q3. This presents a picture in which the top line is...

JELD-WEN Holding (JELD) has reported its latest results with Q4 2025 revenue of US$802 million and a basic EPS loss of US$0.49, while trailing twelve month figures show revenue of about US$3.2 billion and a basic EPS loss of US$7.30. Over recent quarters, the company has seen revenue move from US$895.7 million in Q4 2024 to US$776.0 million in Q1 2025 and then into the US$800 million range in Q2 to Q4 2025. This has come alongside basic EPS losses between roughly US$0.26 and US$4.30 per...

Orthofix Medical (OFIX) opened 2026 by reporting Q1 results that sit against a recent run of quarterly losses, with Q4 2025 revenue at US$219.9 million and a basic EPS loss of US$0.06 on net income loss of US$2.2 million. The trailing twelve months show revenue of US$822.3 million against a basic EPS loss of US$2.33 and a net income loss of US$92.2 million. Over recent quarters, the company has seen revenue move from US$193.6 million in Q1 2025 to US$219.9 million in Q4 2025, while quarterly...

Q1 2026 Earnings Snapshot Lattice Semiconductor (LSCC) has just posted its latest numbers with Q4 2025 revenue at US$145.8 million and a basic EPS loss of US$0.06, setting the stage for how you read the current Q1 2026 update. Over the past few quarters, the company has seen revenue move from US$120.2 million in Q1 2025 to US$145.8 million in Q4 2025, while quarterly basic EPS has ranged from a profit of US$0.04 in Q1 2025 to a loss of US$0.06 in Q4 2025, underscoring how sensitive margins...

Palantir Technologies (PLTR) has set the tone for its Q1 2026 update with trailing 12 month revenue of about US$4.5b, basic EPS of US$0.69 and reported year over year earnings growth of 251.6%. Over the past reported periods, revenue has moved from US$827.5m and basic EPS of US$0.03 in Q4 2024 to US$1.4b and basic EPS of US$0.26 in Q4 2025, with the trailing net profit margin reported at 36.3% versus 16.1% a year earlier. The latest print therefore comes against a backdrop of expanding...

Latest Results Set the Stage for a Margins Conversation BellRing Brands (BRBR) opened its Q2 2026 reporting window with recent quarterly revenue of US$537.3 million and basic EPS of US$0.37, numbers that drop straight into a wider debate about how sustainable its profitability really is. Over the last few reported periods, revenue has moved between US$532.9 million and US$648.2 million while basic EPS has ranged from US$0.17 to US$0.60, giving investors a clear view of how the top line and...

WEC Energy Group (WEC) opened 2026 earnings season with Q1 results anchored by prior year revenue of about US$2.5 billion and basic EPS of US$0.97 in Q4 2025, alongside net income excluding extra items of US$316.6 million. This gave investors a clear read on recent profitability. Over recent quarters the company has seen revenue range from US$2.0 billion to US$3.1 billion, with basic EPS moving between US$0.77 and US$2.28 across 2025 and trailing twelve month EPS of US$4.84 on total revenue...

Integra LifeSciences Holdings (IART) Q1 2026 Earnings Snapshot Integra LifeSciences Holdings (IART) has opened 2026 with Q1 results that sit against a backdrop of recent quarterly revenue between US$380.7 million and US$442.6 million and EPS swinging from a profit of US$0.25 in Q4 2024 to a loss of US$6.31 in Q2 2025 and US$0.02 in Q4 2025. Trailing 12 month EPS stands at a loss of US$6.74 on revenue of about US$1.6 billion. Over the past six reported quarters, revenue has ranged from...

Westlake (WLK) has just posted Q1 2026 results that follow a tough run of earnings, with recent quarterly revenue figures ranging from about US$2.5 billion to US$3.0 billion and EPS moving from a small profit in late 2024 to losses through 2025. Over that span, revenue has moved from US$3,117 million in Q3 2024 to US$2,533 million in Q4 2025, while basic EPS has shifted from US$0.83 to a loss of US$4.23. This has left investors focused squarely on how quickly margins can stabilize from...

Eaton (ETN) has just opened 2026 with Q1 numbers that build on a steady run of results, following Q4 2025 revenue of about US$7.1b and basic EPS of US$2.92 on net income of US$1,132m. Over the past year, the company has seen trailing twelve month revenue move from US$24.9b to US$27.4b, while trailing EPS shifted from US$9.54 to US$10.48, giving you a clear view of how the top and bottom lines have scaled together. With net profit margins recently reported at 14.9%, slightly below last year,...

Scorpio Tankers (STNG) has just posted its latest Q1 2026 update with recent quarterly numbers showing Q4 2025 revenue of US$252.7 million and basic EPS of US$2.72, backed by net income of US$128.1 million. Over the past year, the company has seen quarterly revenue move from US$204.0 million in Q4 2024 to US$214.0 million in Q1 2025, US$230.2 million in Q2, US$241.4 million in Q3 and US$252.7 million in Q4. Over the same period, quarterly EPS shifted from US$1.48 to US$1.26, US$1.59, US$1.81...

Vertex Pharmaceuticals (VRTX) opened 2026 with Q1 results that build on a solid recent run, following Q4 2025 revenue of US$3.2 billion and basic EPS of US$4.69, supported by trailing 12 month revenue of US$12.0 billion and basic EPS of US$15.46. Over the past few quarters, the company has seen revenue move from US$2.8 billion in Q1 2025 to US$3.2 billion in Q4 2025, while basic EPS shifted from US$2.52 to US$4.69. This points to a business where profitability trends are front and center for...

IDEXX Laboratories (IDXX) is coming off a year where trailing twelve month revenue reached about US$4.3 billion and basic EPS was US$13.17, with earnings up 19.3% over the past year. Over recent quarters, revenue has moved from US$954.3 million in Q3 2024 to US$1.1 billion in Q4 2025, while quarterly basic EPS has ranged between roughly US$2.64 and US$3.66, giving you a clear view of how the top and bottom line have been tracking into the latest Q1 2026 update. With net profit margins at...

Advanced Energy Industries (AEIS) has put fresh numbers on the table for Q1 2026, with recent quarterly revenue figures showing a move from US$374.2 million in Q3 2024 to US$489.4 million in Q4 2025 and basic EPS shifting from a loss of US$0.38 in Q3 2024 to US$1.40 in Q4 2025, while trailing twelve month EPS reached US$3.97 on revenue of about US$1.8 billion. Over that stretch, net income excluding extraordinary items moved from a loss of US$14.1 million in Q3 2024 to a profit of US$52.5...

Palladyne AI (PDYN) opened 2026 earnings season with Q1 numbers that follow a mixed 2025, where quarterly revenue ranged from US$0.86 million to US$1.71 million and EPS swung between a loss of US$0.20 and a profit of US$0.64. Over the past year, the company has seen revenue move between US$0.76 million and US$1.71 million per quarter, while EPS shifted from a loss of US$1.82 to a profit of US$0.64. This reflects a business still working through volatile margins, even as the trailing 12 month...